01
Cash & equivalents increased 183.8%
Cash & equivalents changed +183.8% from the comparable as-filed period.
$2.7M→$7.7MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTAkari Therapeutics Plc's latest supported as-filed period reports net income of -$4.8M, 153.7% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +183.8% from the comparable as-filed period.
Net income changed -153.7% from the comparable as-filed period.
Operating income changed -47.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
AKTX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001493152-26-039246SEC ↗8-KAug 13, 2026Period Aug 13, 20260001493152-26-037736SEC ↗10-QAug 13, 2026Period Jun 30, 20260001493152-26-037730SEC ↗4Aug 5, 2026Period Jul 16, 20260001493152-26-036231SEC ↗4Jul 17, 2026Period Jul 7, 20260001493152-26-033634SEC ↗8-KJul 2, 2026Period Jun 30, 20260001493152-26-031972SEC ↗8-KJun 26, 2026Period Jun 23, 20260001493152-26-030341SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 17, 2026Filed Aug 19, 2026 | Farag Kameel D.Interim CFO | Grant Or AwardDirect | 1,728 | $8 | $12,995 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +211.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Selling, general & administrative changed +3.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed -1.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001493152-26-030210